KR20010043828A - ｃＡＭＰ-증강 화합물 단독 또는 감수분열-자극 화합물하나 이상과의 조합에 의한 불임 치료 방법 - Google Patents

ｃＡＭＰ-증강 화합물 단독 또는 감수분열-자극 화합물하나 이상과의 조합에 의한 불임 치료 방법 Download PDF

Info

Publication number
KR20010043828A
KR20010043828A KR1020007013278A KR20007013278A KR20010043828A KR 20010043828 A KR20010043828 A KR 20010043828A KR 1020007013278 A KR1020007013278 A KR 1020007013278A KR 20007013278 A KR20007013278 A KR 20007013278A KR 20010043828 A KR20010043828 A KR 20010043828A
Authority
KR
South Korea
Prior art keywords
enhancing compound
meiosis
compound
stimulating
use according
Prior art date
Application number
KR1020007013278A
Other languages
English (en)
Korean (ko)
Inventor
크리스타 헤겔-하르퉁
쿠옥-람 캄
Original Assignee
에바-마리아 시마-메이어, 얼설라 멜져, 마거, 하르트만
쉐링 악티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에바-마리아 시마-메이어, 얼설라 멜져, 마거, 하르트만, 쉐링 악티엔게젤샤프트 filed Critical 에바-마리아 시마-메이어, 얼설라 멜져, 마거, 하르트만
Publication of KR20010043828A publication Critical patent/KR20010043828A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020007013278A 1998-05-26 1999-05-07 ｃＡＭＰ-증강 화합물 단독 또는 감수분열-자극 화합물하나 이상과의 조합에 의한 불임 치료 방법 KR20010043828A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98250177.7 1998-05-26
EP98250177 1998-05-26
PCT/EP1999/003138 WO1999061010A2 (en) 1998-05-26 1999-05-07 Treatment of infertility with cam-increasing compounds alone or in combination with at least one meiosis-stimulating compound

Publications (1)

Publication Number Publication Date
KR20010043828A true KR20010043828A (ko) 2001-05-25

Family

ID=8234594

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020007013278A KR20010043828A (ko) 1998-05-26 1999-05-07 ｃＡＭＰ-증강 화합물 단독 또는 감수분열-자극 화합물하나 이상과의 조합에 의한 불임 치료 방법

Country Status (7)

Country Link
EP (1) EP1098652A2 (no)
JP (1) JP2002516272A (no)
KR (1) KR20010043828A (no)
AU (1) AU5408999A (no)
CA (1) CA2333320A1 (no)
NO (1) NO20005954D0 (no)
WO (1) WO1999061010A2 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001019354A2 (en) 1999-09-16 2001-03-22 Novo Nordisk A/S Composition for ivf
US6544166B1 (en) 1999-11-25 2003-04-08 Groendahl Christian Treatment of human infertility
WO2001038493A1 (en) * 1999-11-25 2001-05-31 Novo Nordisk A/S Treatment of human infertility
AU2001240624A1 (en) * 2000-02-25 2001-09-03 Novo-Nordisk A/S Improvement of implantation rate
WO2001062260A2 (en) * 2000-02-25 2001-08-30 Schering Aktiengesellschaft Improvement of implantation rate
WO2001076360A2 (en) * 2000-04-06 2001-10-18 Novo Nordisk A/S Synchronization of the cytoplasmatic and the nuclear maturation of oocytes in vitro
EP1147774A1 (en) 2000-04-20 2001-10-24 Stichting Dienst Landbouwkundig Onderzoek Method for improving the quality of sperm for artificial insemination of animals
JP2003533222A (ja) * 2000-05-18 2003-11-11 シエーリング アクチエンゲゼルシャフト 経年卵母細胞の受精
EP1245572A1 (en) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation
IL162506A0 (en) 2001-12-14 2005-11-20 Applied Research Systems Ovulation induction
WO2003070766A2 (en) * 2002-02-22 2003-08-28 Novo Nordisk A/S A transducer of mas signalling
EP2750692B1 (en) 2011-08-30 2016-08-03 Centre National De La Recherche Scientifique Protein complex comprising mcm8 and mcm9 proteins and their use
GB201117453D0 (en) * 2011-10-10 2011-11-23 Univ Dundee Improved sperm function/activity
CN108531447B (zh) * 2018-04-13 2021-11-23 上海市生物医药技术研究院 调节精子运动能力及辅助生殖的化合物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0196530A3 (de) * 1985-03-26 1989-03-22 CTA Finanz AG Mittel und Verfahren zur Beschleunigung des Wachstums, zur Optimierung der Fruchtbarkeit und zur Stimulierung des Immunsystems bei Mensch und Tier
US5716777A (en) * 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols
KR19980702624A (ko) * 1995-03-06 1998-08-05 슈타르 피아 감수분열의 자극
US5800625A (en) * 1996-07-26 1998-09-01 Cauldron Limited Partnership Removal of material by radiation applied at an oblique angle
CA2199663C (en) * 1997-03-11 2004-08-10 Ruth Miriam Moses In vitro maturation and fertilization of mammalian oocytes

Also Published As

Publication number Publication date
WO1999061010A2 (en) 1999-12-02
WO1999061010A3 (en) 2000-04-27
JP2002516272A (ja) 2002-06-04
NO20005954L (no) 2000-11-24
AU5408999A (en) 1999-12-13
EP1098652A2 (en) 2001-05-16
CA2333320A1 (en) 1999-12-02
NO20005954D0 (no) 2000-11-24

Similar Documents

Publication Publication Date Title
US6281013B1 (en) Treatment of Infertility
Wallach et al. Investigation of mammalian ovulation with an in vitro perfused rabbit ovary preparation
KR20010043828A (ko) ｃＡＭＰ-증강 화합물 단독 또는 감수분열-자극 화합물하나 이상과의 조합에 의한 불임 치료 방법
RU2188006C2 (ru) Стимуляция мейоза
US6585982B1 (en) Treatment of infertility
Hinko et al. Characterization of oxytocin receptors in rabbit amnion involved in the production of prostaglandin E2.
US20080311656A1 (en) Meiosis arrest in oocytes in vitro
EP1235899B1 (en) Treatment of human infertility
US6544166B1 (en) Treatment of human infertility
MXPA00009505A (en) TREATMENT OF INFERTILITY WITH cAMP-INCREASING COMPOUNDS ALONE OR IN COMBINATION WITH AT LEAST ONE MEIOSIS-STIMULATING COMPOUND
JP2003529378A (ja) 卵母細胞の細胞質および核成熟の体外成熟方法
US20040224878A1 (en) Fertilization of aged oocytes
WO2001062260A2 (en) Improvement of implantation rate
Meyers Implantation and deciduoma formation after administration of antiestrogenic compounds
US20030153808A1 (en) Implantation rate using ff-mas
ZA200104653B (en) Treatment of infertility.
MXPA01008452A (en) Treatment of infertility
CA2362940A1 (en) Treatment of infertility
MXPA97006565A (es) Estimulacion de meiosis

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid